ARTICLE IN ACADEMIC JOURNALS
| NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
|---|---|
| 1. |
A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectory
2024
Source :
JOURNAL OF HEPATOLOGY
DOI :
10.1016/j.jhep.2024.05.017
|
| 2. |
"An Unusual Pattern of Metastasis" Metastatic Malignant Thymoma Presented with Breast Lump: A Case Report and Literature Review
2023
Source :
CASE REPORTS IN SURGERY
DOI :
10.1155/2023/3114843
|
| 3. |
Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas
2023
Author(s) : Diana Ong Bee Lan Source :
CANCERS
DOI :
10.3390/cancers15020453
|
| 4. |
A genomic enhancer signature associates with hepatocellular carcinoma prognosis
2023
Author(s) : Lim Jasmine, Diana Ong Bee Lan Source :
JHEP Reports
DOI :
10.1016/j.jhepr.2023.100715
|
| 5. |
Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study
2022
Author(s) : Diana Ong Bee Lan Source :
NATIONAL SCIENCE REVIEW
DOI :
10.1093/nsr/nwab192
|
| 6. |
Downregulation of hsa-miR-548d-3p and overexpression of HOXA9 in diffuse large B-cell lymphoma patients and the risk of R-CHOP chemotherapy resistance and disease progression
2022
Source :
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
DOI :
10.1111/ijlh.13928
|
| 7. |
Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in Hepatocellular Carcinoma: the PLANET study
2021
Author(s) : Diana Ong Bee Lan, Yoong Boon Koon Source :
National Science Review
|
| 8. |
Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
2020
Author(s) : Liam Chong Kin, Cheah Phaik Leng, Pang Yong Kek, Ho Gwo Fuang, Adlinda Binti Alip, Poh Mau Ern, Diana Ong Bee Lan Source :
CANCER MANAGEMENT AND RESEARCH
DOI :
10.2147/CMAR.S253760
|
| 9. |
Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
2020
Author(s) : Liam Chong Kin, Cheah Phaik Leng, Pang Yong Kek, Ho Gwo Fuang, Adlinda Binti Alip, Poh Mau Ern, Diana Ong Bee Lan Source :
CANCER MANAGEMENT AND RESEARCH
|
| 10. |
Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
2020
Author(s) : Diana Ong Bee Lan Source :
Cancer Management and Research
DOI :
DOI https://doi.org/10.2147/CMAR.S253760
|
| 11. |
Extranodal site of diffuse large B-cell lymphoma and the risk of R-CHOP chemotherapy resistance and early relapse.
2020
Author(s) : Diana Ong Bee Lan, Gan Shiaw Sze @ Gan Gin Gin Source :
The International Journal of Clinical Practice
DOI :
DOI: 10.1111/ijcp.13594
|
| 12. |
Extranodal site of diffuse large B-cell lymphoma and the risk of R-CHOP chemotherapy resistance and early relapse
2020
Source :
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
DOI :
10.1111/ijcp.13594
|
| 13. |
Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors
2019
Author(s) : Diana Ong Bee Lan Source :
JOURNAL OF THORACIC ONCOLOGY
DOI :
DOI:https://doi.org/10.1016/j.jtho.2019.08.2302
|
| 14. |
Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.
2019
Source :
Malaysian Journal of Pathology
|
| 15. |
Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer
2019
Author(s) : Ong Kien Chai, Shanggar A/l Kuppusamy, Lim Jasmine, Azad Hassan Bin Abdul Razack, Diana Ong Bee Lan Source :
Malaysian Journal of Pathology
|
| 16. |
Clinical significance of aberrant microRNA expression in predicting disease relapse/ refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis
2019
Author(s) : Diana Ong Bee Lan Source :
Critical Reviews in Oncology/ Hematology
|
| 17. |
Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis
2019
Source :
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
|
| 18. |
Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer
2019
Author(s) : Azad Hassan Bin Abdul Razack, Ong Kien Chai, Shanggar A/l Kuppusamy, Lim Jasmine, Charles Anthony Rhodes, Diana Ong Bee Lan Source :
MALAYSIAN JOURNAL OF PATHOLOGY
|
| 19. |
DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
2018
Source :
PeerJ
|
| 20. |
DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma.
2018
Author(s) : Cheah Phaik Leng, Diana Ong Bee Lan Source :
Peer Journal
|
| 21. |
Heterogenous expression of ERG oncoprotein in Malaysian men with adenocarcinoma of the prostate
2018
Source :
Malaysian Journal of Pathology
|
| 22. |
E-cadherin downregulation at the infiltrating tumour front is associated with histological grade and stage in colorectal carcinoma of Malaysians
2015
Author(s) : Diana Ong Bee Lan, Cheah Phaik Leng Source :
The Malaysian Journal of Pathology
|
| 23. |
Enterobius vermicularis salpingitis seen in the setting of ectopic pregnancy in a Malaysian patient
2014
Author(s) : Chow Tak Kuan, Dr Sarala Ravindran, Rohela Binti Mahmud, Yvonne Lim Ai Lian, Romano Ngui, Diana Ong Bee Lan, Syeda Nureena Binti Syed Jafer Hussain Zaidi Source :
Journal of Clinical Microbiology
|
RESEARCH PROJECT
| GRANT | PROGRESS | STATUS |
|---|---|---|
|
Elucidating The Molecular Mechanisms Of Exosomal Circltbp2-mediated Temozolomide Resistance In Glioblastoma Via C-met/stat3 Pathway And Mgmt Acetylation
Researcher(s) : Dr. Diana Ong Bee Lan, Dr. Phang Kean Chang, Li Qiang |
|
on going |
RESEARCH COLLABORATOR
| GRANT | PROGRESS | STATUS |
|---|---|---|
|
Elucidating The Molecular Mechanisms Of Exosomal Circltbp2-mediated Temozolomide Resistance In Glioblastoma Via C-met/stat3 Pathway And Mgmt Acetylation
Researcher(s) : Dr. Diana Ong Bee Lan, Dr. Phang Kean Chang, Li Qiang |
|
on going |